SCHEMBL24200439

SCHEMBL24200439

COc1ccc2c(c1)c1ncnc(-c3ccccc3C=O)c1n2C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 14/20 0.55
ALDH1A1 P00352 14/20 0.55
HPGD P15428 10/20 0.55
GLA P06280 7/20 0.55
HSD17B10 Q99714 6/20 0.55
GAA P10253 6/20 0.55
HTT P42858 5/20 0.55
RXFP1 Q9HBX9 3/20 0.55
TSHR P16473 2/20 0.55
MAPK1 P28482 2/20 0.55
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.49
MAPT P10636 3/20 0.47
PKM P14618 2/20 0.43
MAPK10 P53779 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24200430 0.74 KDM4E (0.70) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL20158977 0.73 KDM4E (0.68) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL21341228 0.71 KDM4E (0.45) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL24200393 0.70 RET (0.40) ALDH1A1HPGDHTTMAPK1LMNA
SCHEMBL31232939 0.69 BCHE (0.54) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL24200425 0.69 ALKBH5 (0.41) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL20159028 0.68 KDM4E (0.54) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL3677398 0.66 ERN1 (0.56) KDM4EALDH1A1MAPK1LMNAMAPT
SCHEMBL14956243 0.66 BCHE (0.59) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL343958 0.66 TRIM24 (0.65) ALDH1A1HPGDGAAHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538529-B1 SELECTIVE INHIBITORS OF GENOTOXIC STRESS-INDUCED IKK/NF-KB PATHWAYS MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT (DE) 2022-01-19 EP disclosed